4TakanoriMaruyama,YoshikiMizukami,YoshihikoKawaguchi,KousakuMimura,MitsuakiWatanabe,ShinichirouIzawa,HidekiFujii.Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor‐infiltrating lymphocytes, tumor‐draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer[J]. Cancer Science . 2010 (9)
5Hazel Tye,Catherine L. Kennedy,Meri Najdovska,Louise McLeod,William McCormack,Norman Hughes,Anouk Dev,William Sievert,Chia Huey Ooi,Tomo-o Ishikawa,Hiroko Oshima,Prithi S. Bhathal,Andrew E. Parker,Masanobu Oshima,Patrick Tan,Brendan J. Jenkins.STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation[J]. Cancer Cell . 2012 (4)
6Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742)
7Donald Richards,Darren M. Kocs,Alexander I. Spira,A. David McCollum,Sami Diab,Lanny I. Hecker,Allen Cohn,Feng Zhan,Lina Asmar.Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomized phase 2 study[J].European Journal of Cancer.2013
8Terence C.Chua,Neil D.Merrett.Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review[J].Int J Cancer.2012(12)
9P.Allavena,A.Mantovani.Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment[J].Clinical & Experimental Immunology.2012(2)
10Heike Grabsch,Shivan Sivakumar,Sally Gray,Helmut E. Gabbert,Wolfram Müller.HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series[J].Cellular Oncology (-).2010(1-2)
